The National Research Technological University of Russia - NUST MISIS is a dynamic scientific and educational center attracting the best graduates, scientists, and lecturers. The University specifically focuses on integrating science, education, and innovations, as well as establishing a creative environment for unlocking the potential of every student.
No End to Cancer in Upcoming Decades
Scientists & Researchers of NUST MISIS held a video press conference/interaction with Indian media and science enthusiasts on Wednesday in New Delhi.
Maxim Abakumov, Head of the Laboratory "Biomedical Nanomaterials" NITU "MISiS" said that despite the new methods & developments in treating it, Cancer is still very much prevalent. Cancer is directly related to the development of the society, the more developed society is more chances of cancer exist. There is certainly some success, as some forms of cancers which were not curable before are now curable. However, there seems to be no end of Cancer in next few decades.
In response to a question on the causes of cancer, Maxim Abakumov said," cancer, oncological diseases are caused mainly by Contamination of environment, pollution, inappropriate waste management. There could be a combination of various factors which cause cancer and it is not possible to identify one particular cause and say that don't do that and you will not get cancer. Unfortunately, that is not the case, maybe someday they will find the cause but that is not the case as on date."
Sergey Kaloshkin, Director of the Institute of New Materials and Nanotechnologies of the NUST MISIS along with other researchers and experts discussed and demonstrated various research projects they have been working on tumors, tissue engineering, devise for early diagnosis, and development of new materials for medical use. Discussions revolved around the developments in the field of health and medicine in Russia and India, including in partnership with the international scientific community, which can be applied in various fields and not only in medicine.
Sergey Kolashkin explained that The National University of Science and Technology is presently providing Science Education to more than 15 thousand students including 3600 foreign Students from 69 countries. Last year 9 Indian students completed their post-graduation from MISiS.
MISiS has a cooperation agreement with Saha Institute of Nuclear Physics in Kolkata, India. They are carrying out their research on developing Nanoparticles that fight against tumors. Apart from that they jointly work with Institute of Technology in Delhi on fundamental research of magnetic properties of new alloys for next decades
Alexander Osipov, leading researcher of the Department of Functional Nanosystems and High-Temperature Materials of the NUST MISIS said that the motto of NUST MISIS is to invent the technologies to make diagnose easily so that diseases could be detected in earlier stages.
Emphasizing joint work of NUST MISIS & Indian Scientist Dr. Senapati Dulal from Saha Institute of Nuclear Physics in Kolkata, Alexander Osipov said that this work in the sphere of Gold Nanoflowers and Nanospheres was highly appreciated and is funded by Russian Ministry of Education & Science and Department of Biotechnology India.
He further stressed that we need to have access to cheap preliminary diagnostic, self-diagnosis applications with preventive approach available for all to have early detection.
The experts also explained that by 2020, NUST MISIS intends to strengthen its leadership positions in a number of areas, including material sciences, metallurgy, and mining, as well as strongly strengthen its presence in biomaterials, nano- and IT-technologies.
In a response to the question on the pricing of the practical applications these developments for the patients or end users, experts expressed inability to predict a concrete price due various other factors of market and investment involved however they were of the opinion that with their research work they expect the prices to come down to half of the similar treatment as on current date.